We report the application of cationic tri- and tetra-nuclear gold(I) phosphine complexes [Au3(μ-dppen)3]X3 and [Au4(μ-dppa)4]X4 (X = OTf, PF6) [OTf = trifluoromethanesulfonate, dppen = trans-1,2-bis(diphenylphosphino)ethene, dppa = bis(diphenylphosphino)acetylene] for cancer treatment. The results of cytotoxicity tests on four different cancer cells [prostate (DU145), cervical (HeLa), breast (MDAMB-231) and fibro sarcoma (HT1080)] indicate these complexes possess remarkable tumor cell growth inhibitory effects and high selectivity towards cancer cells. The anti-tumor mechanism of the tri- and tetra-nuclear gold(I) complexes has also been investigated.
CITATION STYLE
Reddy, T. S., Privér, S. H., Mirzadeh, N., & Bhargava, S. K. (2017). Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety. Journal of Inorganic Biochemistry, 175, 1–8. https://doi.org/10.1016/j.jinorgbio.2017.06.010
Mendeley helps you to discover research relevant for your work.